Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Alzheimer's Disease: Genes, Proteins, and Therapy

Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

High-Level Neuronal Expression of Aβ1–42in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation

Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611

Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease

Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324

Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models

Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123

Amyloid fibrillogenesis: themes and variations

Rochet, J., & Lansbury, P. T. (2000) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)00049-4 · Cited by 1,095

Amyloid β-Protein Fibrillogenesis

Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046

Increased soluble amyloid-β peptide and memory deficits in amyloid model mice overexpressing the low-density lipoprotein receptor-related protein

Zerbinatti, C. V., Wozniak, D. F., Cirrito, J., Cam, J. A., Osaka, H., Bales, K. R., Zhuo, M., Paul, S. M., Holtzman, D. M., & Bu, G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305803101 · Cited by 133

Amyloid deposits: Protection against toxic protein species?

Treusch, S., Cyr, D., & Lindquist, S. L. (2009) · Cell Cycle · doi:10.4161/cc.8.11.8503 · Cited by 138

NSAID and Antioxidant Prevention of Alzheimer's Disease: Lessons from In Vitro and Animal Models

COLE, G. M., MORIHARA, T., LIM, G. P., YANG, F., BEGUM, A., & FRAUTSCHY, S. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1332.005 · Cited by 129

New developments on the role of NMDA receptors in Alzheimer's disease

Malinow, R. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.001 · Cited by 132

LRP in Amyloid‐β Production and Metabolism

Bu, G., Cam, J. A., & Zerbinatti, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.005 · Cited by 141

β-Secretase-Cleaved Amyloid Precursor Protein Accumulates at Actin Inclusions Induced in Neurons by Stress or Amyloid β: A Feedforward Mechanism for Alzheimer's Disease

Maloney, M. T., Minamide, L. S., Kinley, A. W., Boyle, J. A., & Bamburg, J. R. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.3711-05.2005 · Cited by 140

Neuropathology of Alzheimer disease: pathognomonic but not pathogenic

Castellani, R. J., Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0071-y · Cited by 133

Ideas of order for amyloid fibril structure.

Wetzel, R. (2002) · Structure · doi:10.1016/s0969-2126(02)00809-2 · Cited by 144

Expression of β-Amyloid Induced Age-Dependent Presynaptic and Axonal Changes in Drosophila

Zhao, X.-L., Wang, W.-A., Tan, J.-X., Huang, J.-K., Zhang, X., Zhang, B.-Z., Wang, Y.-H., YangCheng, H.-Y., Zhu, H.-L., Sun, X.-J., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.3699-09.2010 · Cited by 130

Pathway Complexity of Alzheimer's β-Amyloid Aβ16-22 Peptide Assembly

Santini, S., Wei, G., Mousseau, N., & Derreumaux, P. (2004) · Structure · doi:10.1016/j.str.2004.04.018 · Cited by 131

L-3-n-Butylphthalide Improves Cognitive Impairment and Reduces Amyloid- in a Transgenic Model of Alzheimer's Disease

Peng, Y., Sun, J., Hon, S. M., Nylander, A., Xia, W., Feng, Y., Wang, X., & Lemere, C. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0340-10.2010 · Cited by 133

Oligomeric and fibrillar species of β-amyloid (Aβ42) both impair mitochondrial function in P301L tau transgenic mice

Eckert, A., Hauptmann, S., Scherping, I., Meinhardt, J., Rhein, V. F., Dröse, S., Brandt, U., Fändrich, M., Müller, W. E., & Götz, J. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0391-6 · Cited by 132

Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments

Levenga, J., Krishnamurthy, P., Rajamohamedsait, H. B., Wong, H., Franke, T. F., Cain, P., Sigurdsson, E. M., & Hoeffer, C. A. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-34 · Cited by 131

Alzheimer's disease: insights from Drosophila melanogaster models

Moloney, A. M., Sattelle, D. B., Lomas, D. A., & Crowther, D. C. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.11.004 · Cited by 135

Black Tea Theaflavins Inhibit Formation of Toxic Amyloid-β and α-Synuclein Fibrils

Grelle, G., Otto, A., Lorenz, M., Frank, R. F., Wanker, E. E., & Bieschke, J. (2011) · Biochemistry · doi:10.1021/bi2012383 · Cited by 133

Synaptic dysfunction and septin protein family members in neurodegenerative diseases

Marttinen, M., Kurkinen, K. M. A., Soininen, H. S., Haapasalo, A., & Hiltunen, M. O. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0013-z · Cited by 138

p21-activated Kinase-aberrant Activation and Translocation in Alzheimer Disease Pathogenesis

Ma, Q., Yang, F., Calon, F., Ubeda, O. J., Hansen, J. E., Weisbart, R. H., Beech, W. K., Frautschy, S. A., & Cole, G. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708034200 · Cited by 131

Calcium Ions Promote Formation of Amyloid β-Peptide (1–40) Oligomers Causally Implicated in Neuronal Toxicity of Alzheimer's Disease

Itkin, A., Duprès, V., Dufrêne, Y. F., Bechinger, B., Ruysschaert, J., & Raussens, V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018250 · Cited by 131

A Noncompetitive BACE1 Inhibitor TAK-070 Ameliorates Aβ Pathology and Behavioral Deficits in a Mouse Model of Alzheimer's Disease

Fukumoto, H., Takahashi, H., Tarui, N., Matsui, J., Tomita, T., Hirode, M., Sagayama, M., Maeda, R., Kawamoto, M., Hirai, K., et al. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.2884-10.2010 · Cited by 130

Biometals and Their Therapeutic Implications in Alzheimer's Disease

Ayton, S., Lei, P., & Bush, A. I. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0312-z · Cited by 134

Pathophysiology of Alzheimer's Disease

Imbimbo, B. P., Lombard, J., & Pomara, N. (2005) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2005.09.009 · Cited by 137

The role of copper ions in pathophysiology and fluorescent sensors for the detection thereof

Verwilst, P., Sunwoo, K., & Kim, J. S. (2015) · Chemical Communications · doi:10.1039/c4cc10366a · Cited by 133

Z-ligustilide: A review of its pharmacokinetics and pharmacology.

Xie, Q., Zhang, L., Xie, L., Zheng, Y., Liu, K., Tang, H., Liao, Y., & Li, X. (2020) · Phytotherapy Research · doi:10.1002/ptr.6662 · Cited by 108

Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases

Rinauro, D. J., Chiti, F., Vendruscolo, M., & Limbocker, R. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00651-2 · Cited by 138

Alzheimer’s disease as oligomeropathy

Ono, K. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.010 · Cited by 129

The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: It's time for reconciliation

Barone, E., Di Domenico, F., Mancuso, C., & Butterfield, D. A. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.09.018 · Cited by 127

The lipid peroxidation products 4-oxo-2-nonenal and 4-hydroxy-2-nonenal promote the formation of α-synuclein oligomers with distinct biochemical, morphological, and functional properties

Näsström, T., Fagerqvist, T., Barbu, M., Karlsson, M., Nikolajeff, F. K., Kasrayan, A., Ekberg, M., Lannfelt, L., Ingelsson, M., & Bergström, J. J. E. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.11.027 · Cited by 132

Synaptic plasticity: one STEP at a time

Braithwaite, S. P., Paul, S., Nairn, A. C., & Lombroso, P. J. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.06.007 · Cited by 129

Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling

Sousa, M. M., & Saraiva, M. J. (2003) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2003.11.002 · Cited by 132

Amyloid-β effects on synapses and memory require AMPA receptor subunit GluA3

Reinders, N. R., Pao, Y., Renner, M., Matos, C. D. S., Lodder, T. R., Malinow, R., & Kessels, H. W. H. G. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614249113 · Cited by 131

IL‐4 attenuates the neuroinflammation induced by amyloid‐β in vivo and in vitro

Lyons, A., Griffin, R. J., Costelloe, C., Clarke, R. M., & Lynch, M. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04370.x · Cited by 129

Physicochemical characteristics of soluble oligomeric Aβand their pathologic role in Alzheimer's disease

Watson, D., Castaño, E., Kokjohn, T. A., Kuo, Y., Lyubchenko, Y. L., Pinsky, D. J., Connolly, E. S., Esh, C. L., Luehrs, D. C., Stine, W. B., et al. (2005) · Neurological Research · doi:10.1179/016164105x49436 · Cited by 129

Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin

Busch, A., Engemann, S., Lurz, R., Okazawa, H., Lehrach, H., & Wanker, E. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303354200 · Cited by 134

Visuospatial function in the beagle dog: An early marker of cognitive decline in a model of human aging and dementia

Studzinski, C. M., Christie, L., ARAUJO, J., Burnham, W. M., Head, E., Cotman, C. W., & Milgram, N. W. (2006) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2006.02.005 · Cited by 133

In Silico Assembly of Alzheimer's Aβ16-22 Peptide into β-Sheets

Santini, S., Mousseau, N., & Derreumaux, P. (2004) · Journal of the American Chemical Society · doi:10.1021/ja047286i · Cited by 129

FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer’s disease

Kam, T.-I., Song, S., Gwon, Y., Park, H., Yan, J.-J., Im, I., Choi, J.-W., Choi, T.-Y., Kim, J., Song, D.-K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66827 · Cited by 128

Protein Denaturation and Aggregation

Meredith, S. C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1363.030 · Cited by 130

Variations in the neuropathology of familial Alzheimer’s disease

Shepherd, C. E., McCann, H., & Halliday, G. M. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0521-4 · Cited by 135

The E693Δ Mutation in Amyloid Precursor Protein Increases Intracellular Accumulation of Amyloid β Oligomers and Causes Endoplasmic Reticulum Stress-Induced Apoptosis in Cultured Cells

Nishitsuji, K., Tomiyama, T., Ishibashi, K., Ito, K., Teraoka, R., Lambert, M. P., Klein, W. L., & Mori, H. (2009) · The American Journal of Pathology · doi:10.2353/ajpath.2009.080480 · Cited by 127

MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer’s disease

Baranger, K., Marchalant, Y., Bonnet, A. E., Crouzin, N., Carrete, A., Paumier, J.-M., Py, N. A., Bernard, A., Bauer, C., Charrat, E., et al. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1992-1 · Cited by 133

Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort

Valcour, V., Shikuma, C. M., Shiramizu, B. T., Watters, M. R., Poff, P., Selnes, O. A., Grove, J., Liu, Y., Abdul-Majid, K.-B., Gartner, S., et al. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.08.029 · Cited by 127

Aluminum-triggered structural modifications and aggregation of β-amyloids

Ricchelli, F., Drago, D., Filippi, B., Tognon, G., & Zatta, P. F. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5141-0 · Cited by 128

β-Barrel Topology of Alzheimer's β-Amyloid Ion Channels

Jang, H., Arce, F. T., Ramachandran, S., Capone, R. F., Lal, R., & Nussinov, R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.10.025 · Cited by 131

Soluble Amyloid-beta Aggregates from Human Alzheimer’s Disease Brains

Esparza, T. J., Wildburger, N. C., Jiang, H., Gangolli, M., Cairns, N. J., Bateman, R. J., & Brody, D. L. (2016) · Scientific Reports · doi:10.1038/srep38187 · Cited by 127

PI3 kinase signaling is involved in Aβ-induced memory loss in Drosophila

Chiang, H., Wang, L., Xie, Z., Yau, A., & Zhong, Y. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909314107 · Cited by 127

Alzheimer’s amyloid β-peptide (1–42): involvement of methionine residue 35 in the oxidative stress and neurotoxicity properties of this peptide

Butterfield, D. A., & Bush, A. I. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.027 · Cited by 129

Antibodies against β‐amyloid reduce aβ oligomers, glycogen synthase kinase‐3β activation and τ phosphorylation in vivo and in vitro

Ma, Q., Lim, G. P., Harris‐White, M. E., Yang, F., Ambegaokar, S. S., Ubeda, O. J., Glabe, C. G., Teter, B., Frautschy, S. A., & Cole, G. M. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20734 · Cited by 126

Accelerated Age-Related Cognitive Decline and Neurodegeneration, Caused by Deficient DNA Repair

Borgesius, N. Z., de Waard, M. C., van der Pluijm, I., Omrani, A., Zondag, G. C. M., van der Horst, G. T. J., Melton, D. W., Hoeijmakers, J. H. J., Jaarsma, D., & Elgersma, Y. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1589-11.2011 · Cited by 134

Amyloid Beta-Related Alterations to Glutamate Signaling Dynamics During Alzheimer’s Disease Progression

Findley, C. A., Bartke, A., Hascup, K. N., & Hascup, E. R. (2019) · ASN NEURO · doi:10.1177/1759091419855541 · Cited by 133

β-sheet breaker peptide prevents Aβ-induced spatial memory impairments with partial reduction of amyloid deposits

Chacón, M. A., Barría, M. I., Soto, C. A., & Inestrosa, N. C. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001516 · Cited by 129

Protein misfolding in neurodegenerative diseases

Agorogiannis, E. I., Agorogiannis, G. I., Papadimitriou, A., & Hadjigeorgiou, G. M. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00558.x · Cited by 127

Activation of the neuronal c-Abl tyrosine kinase by amyloid-β-peptide and reactive oxygen species

Alvarez, A. R., Sandoval, P. C., Leal, N. R., Castro, P. U., & Kosik, K. S. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.06.007 · Cited by 125

Pathophysiology and treatment of systemic amyloidosis

Gillmore, J., & Hawkins, P. (2013) · Nature Reviews Nephrology · doi:10.1038/nrneph.2013.171 · Cited by 113

Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin

Ultsch, M., Li, B., Maurer, T., Mathieu, M., Adolfsson, O., Muhs, A., Pfeifer, A., Pihlgren, M., Bainbridge, T. W., Reichelt, M., et al. (2016) · Scientific Reports · doi:10.1038/srep39374 · Cited by 124

Ciliary Neurotrophic Factor Cell-Based Delivery Prevents Synaptic Impairment and Improves Memory in Mouse Models of Alzheimer's Disease

Garcia, P., Youssef, I., Utvik, J. K., Florent-Béchard, S., Barthélémy, V., Malaplate-Armand, C., Kriem, B., Stenger, C., Koziel, V., Olivier, J.-L., et al. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4182-09.2010 · Cited by 139

Alzheimer’s disease due to loss of function: A new synthesis of the available data

Kepp, K. P. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.06.004 · Cited by 123

Identification of on- and off-pathway oligomers in amyloid fibril formation

Dear, A. J., Meisl, G., Šarić, A., Michaels, T. C. T., Kjærgaard, M., Linse, S. S., & Knowles, T. P. J. (2020) · Chemical Science · doi:10.1039/c9sc06501f · Cited by 126

Memantine lowers amyloid‐β peptide levels in neuronal cultures and in APP/PS1 transgenic mice

Alley, G. M., Bailey, J. A., Chen, D., Ray, B., Puli, L., Tanila, H., Banerjee, P., & Lahiri, D. K. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22172 · Cited by 126

Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-β protein

Calabrese, B., Shaked, G. M., Tabarean, I. V., Braga, J., Koo, E. H., & Halpain, S. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.02.006 · Cited by 129

Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease

Marzolo, M.-P., & Bu, G. (2009) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2008.10.005 · Cited by 122

Apathy correlates with prefrontal amyloid deposition in Alzheimer's disease

Mori, T., Shimada, H., Shinotoh, H., Hirano, S., Eguchi, Y., Yamada, M., Fukuhara, R., Tanimukai, S., Zhang, M.-R., Kuwabara, S., et al. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-306110 · Cited by 122

Untitled work

Askanas (2006) · doi:10.1212/01.wnl.0000192128.13875.1e · Cited by 168

Amyloid deposition detected with florbetapir F 18 (18F-AV-45) is related to lower episodic memory performance in clinically normal older individuals

Sperling, R. A., Johnson, K. A., Doraiswamy, P. M., Reiman, E. M., Fleisher, A., Sabbagh, M. N., Sadowsky, C., Carpenter, A. P., Davis, M. D., Lu, M., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.06.014 · Cited by 127

Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Aβ assembly forms throughout life

Shankar, G. M., Leissring, M. A., Adame, A., Sun, X., Spooner, E., Masliah, E., Selkoe, D. J., Lemere, C. A., & Walsh, D. M. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.021 · Cited by 126

Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers

Umeda, T., Ono, K., Sakai, A., Yamashita, M., Mizuguchi, M., Klein, W. L., Yamada, M., Mori, H., & Tomiyama, T. (2016) · Brain · doi:10.1093/brain/aww042 · Cited by 124

Mutant SOD1 linked to familial amyotrophic lateral sclerosis, but not wild-type SOD1, induces ER stress in COS7 cells and transgenic mice

Tobisawa, S., Hozumi, Y., Arawaka, S., Koyama, S., Wada, M., Nagai, M., Aoki, M., Itoyama, Y., Goto, K., & Kato, T. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00353-x · Cited by 128

Sequence Determinants of Enhanced Amyloidogenicity of Alzheimer Aβ42 Peptide Relative to Aβ40

Kim, W., & Hecht, M. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505763200 · Cited by 123

Amyloid-β nanotubes are associated with prion protein-dependent synaptotoxicity

Nicoll, A. J., Panico, S., Freir, D. B., Wright, D., Terry, C., Risse, E., Herron, C. E., O’Malley, T., Wadsworth, J. D. F., Farrow, M. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3416 · Cited by 119

The amyloid cascade and Alzheimer's disease therapeutics: theory versus observation

Castellani, R. J., Plascencia‐Villa, G., & Perry, G. L. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0231-z · Cited by 130

Association between frontal cortex oxidative damage and beta-amyloid as a function of age in Down syndrome

Cenini, G., Dowling, A. L. S., Beckett, T. L., Barone, E., Mancuso, C., Murphy, M. P., LeVine, H., Lott, I. T., Schmitt, F. A., Butterfield, D. A., et al. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.10.001 · Cited by 126

Dissociation between the Processivity and Total Activity of γ-Secretase: Implications for the Mechanism of Alzheimer's Disease-Causing Presenilin Mutations

Quintero-Monzon, O., Martin, M. M., Fernandez, M. A., Cappello, C. A., Krzysiak, A. J., Osenkowski, P., & Wolfe, M. S. (2011) · Biochemistry · doi:10.1021/bi2007146 · Cited by 118

Amyloid-β Peptide: Dr. Jekyll or Mr. Hyde?

Puzzo, D., & Arancio, O. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129033 · Cited by 134

Compounding artefacts with uncertainty, and an amyloid cascade hypothesis that is ‘too big to fail’

Castellani, R. J., & Smith, M. A. (2011) · The Journal of Pathology · doi:10.1002/path.2885 · Cited by 129

Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-A antibody

Bales, K. R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27120 · Cited by 123

Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway

Goodger, Z., Rajendran, L., Trutzel, A., Kohli, B. M., Nitsch, R., & Konietzko, U. (2009) · Journal of Cell Science · doi:10.1242/jcs.048090 · Cited by 131

Protein Tyrosine Phosphatase 1B (PTP1B): A Potential Target for Alzheimer’s Therapy?

Vieira, M. N. N., Silva, N. M. L. E., Ferreira, S. T., & Felice, F. G. D. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00007 · Cited by 123

Re-emphasizing early Alzheimer’s disease pathology starting in select entorhinal neurons, with a special focus on mitophagy

Kobro-Flatmoen, A., Lagartos-Donate, M. J., Aman, Y., Edison, P., Witter, M. P., & Fang, E. F. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101307 · Cited by 119

Neuronal Network Excitability in Alzheimer’s Disease: The Puzzle of Similar versus Divergent Roles of Amyloid β and Tau

Kazim, S. F., Seo, J. H., Bianchi, R., Larson, C. S., Sharma, A., Wong, R. K. S., Gorbachev, K., & Pereira, A. C. (2021) · eNeuro · doi:10.1523/eneuro.0418-20.2020 · Cited by 120

Alzheimer’s β-peptide oligomer formation at physiologic concentrations

LeVine, H. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.08.014 · Cited by 125

Inhibition of Proteasomal Activity Causes Inclusion Formation in Neuronal and Non-Neuronal Cells Overexpressing Parkin

Ardley, H. C., Scott, G. B., Rose, S. A., Tan, N. G. S., Markham, A. F., & Robinson, P. A. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0078 · Cited by 120

Involvement of β-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity

Ma, H., Lesné, S., Kotilinek, L., Steidl-Nichols, J. V., Sherman, M. A., Younkin, L. H., Younkin, S. G., Forster, C. L., Sergeant, N., Delacourte, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609521104 · Cited by 121

Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau

Rayaprolu, S., Higginbotham, L., Bagchi, P., Watson, C. M., Zhang, T., Levey, A. I., Rangaraju, S., & Seyfried, N. T. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00840-3 · Cited by 118

Amyloid- Impairs Synaptic Inhibition via GABAA Receptor Endocytosis

Ulrich, D. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.0950-15.2015 · Cited by 121

Isoflurane-Induced Apoptosis: A Potential Pathogenic Link Between Delirium and Dementia

Xie, Z., Dong, Y., Maeda, U., Moir, R. D., Inouye, S. K., Culley, D. J., Crosby, G., & Tanzi, R. E. (2006) · The Journals of Gerontology Series A · doi:10.1093/gerona/61.12.1300 · Cited by 120

Silent Allosteric Modulation of mGluR5 Maintains Glutamate Signaling while Rescuing Alzheimer’s Mouse Phenotypes

Haas, L. T., Salazar, S. V., Smith, L. M., Zhao, H. R., Cox, T. O., Herber, C. S., Degnan, A. P., Balakrishnan, A. S., Macor, J. E., Albright, C. F., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.06.023 · Cited by 121

High molecular weight amyloid β 1‐42 oligomers induce neurotoxicity via plasma membrane damage

Yasumoto, T., Takamura, Y., Tsuji, M., Watanabe‐Nakayama, T., Imamura, K., Inoue, H., Nakamura, S., Inoue, T., Kimura, A., Yano, S., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201900604r · Cited by 124

Therapeutic Strategies for Alzheimer’s Disease

Barten, D. M., & Albright, C. F. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8031-2 · Cited by 124

Noncanonical function of an autophagy protein prevents spontaneous Alzheimer’s disease

Heckmann, B. L., Teubner, B. J. W., Boada-Romero, E., Tummers, B., Guy, C., Fitzgerald, P., Mayer, U., Carding, S., Zakharenko, S. S., Wileman, T., et al. (2020) · Science Advances · doi:10.1126/sciadv.abb9036 · Cited by 114

Aberrant subcellular neuronal calcium regulation in aging and Alzheimer's disease

Camandola, S., & Mattson, M. P. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.10.005 · Cited by 128

Hemoglobin-derived Peptides as Novel Type of Bioactive Signaling Molecules

Gomes, I., Dale, C. S., Casten, K., Geigner, M. A., Gozzo, F. C., Ferro, E. S., Heimann, A. S., & Devi, L. A. (2010) · The AAPS Journal · doi:10.1208/s12248-010-9217-x · Cited by 122

Reducing Amyloid Plaque Burden via Ex Vivo Gene Delivery of an Aβ-Degrading Protease: A Novel Therapeutic Approach to Alzheimer Disease

Hemming, M. L., Patterson, M., Reske-Nielsen, C., Lin, L., Ole Isacson, A., & Selkoe, D. J. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040262 · Cited by 121

APP/Aβ structural diversity and Alzheimer's disease pathogenesis

Roher, A. E., Kokjohn, T. A., Clarke, S. G., Sierks, M. R., Maarouf, C. L., Serrano, G. E., Sabbagh, M., & Beach, T. G. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.08.007 · Cited by 126

Kinetic characterization of amyloid-beta 1–42 aggregation with a multimethodological approach

Bartolini, M., Naldi, M., Fiori, J., Valle, F., Biscarini, F., Nicolau, D. V., & Andrisano, V. (2011) · Analytical Biochemistry · doi:10.1016/j.ab.2011.03.020 · Cited by 123

Role of α-Synuclein in Adult Neurogenesis and Neuronal Maturation in the Dentate Gyrus

Winner, B., Regensburger, M., Schreglmann, S. R., Boyer, L. F., Prots, I., Rockenstein, E. M., Mante, M., Zhao, C., Winkler, J., Masliah, E., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.2723-12.2012 · Cited by 124

Amyloid β−Cu2+Complexes in both Monomeric and Fibrillar Forms Do Not Generate H2O2Catalytically but Quench Hydroxyl Radicals

Nadal, R. C., Rigby, S. E. J., & Viles, J. H. (2008) · Biochemistry · doi:10.1021/bi8011093 · Cited by 119

Recent rodent models for Alzheimer’s disease: clinical implications and basic research

Braidy, N., Muñoz, P., Palacios, A. G., Castellano‐González, G., Inestrosa, N. C., Chung, R. S., Sachdev, P. S., & Guillemin, G. J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0731-5 · Cited by 126

Cu(II) Binding to Monomeric, Oligomeric, and Fibrillar Forms of the Alzheimer’s Disease Amyloid-β Peptide

Karr, J. W., & Szalai, V. A. (2008) · Biochemistry · doi:10.1021/bi702423h · Cited by 119

Diabetes Mellitus Induces Alzheimer’s Disease Pathology: Histopathological Evidence from Animal Models

Kimura, N. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040503 · Cited by 120

Effects of secreted oligomers of amyloid β‐protein on hippocampal synaptic plasticity: a potent role for trimers

Townsend, M., Shankar, G. M., Mehta, T., Walsh, D. M., & Selkoe, D. J. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2005.103754 · Cited by 619

Certain Inhibitors of Synthetic Amyloid β-Peptide (Aβ) Fibrillogenesis Block Oligomerization of Natural Aβ and Thereby Rescue Long-Term Potentiation

Walsh, D. M., Townsend, M., Podlisny, M. B., Shankar, G. M., Fadeeva, J. V., El‐Agnaf, O. M. A., Hartley, D. M., & Selkoe, D. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4391-04.2005 · Cited by 295

Amyloid β protein immunotherapy neutralizes Aβ oligomers that disrupt synaptic plasticity in vivo

Klyubin, I., Walsh, D. M., Lemere, C. A., Cullen, W. K., Shankar, G. M., Betts, V., Spooner, E. T., Jiang, L., Anwyl, R., Selkoe, D. J., et al. (2005) · Nature Medicine · doi:10.1038/nm1234 · Cited by 489

P2‐399: RESTORING LONG‐TERM POTENTIATION IMPAIRED BY AMYLOID‐BETA OLIGOMERS: COMPARISON OF A BROADLY‐SPECIFIC ANTI AMYLOID‐BETA NANOBODY AND A MONOMER‐SPECIFIC ANTIBODY

Kroker, K. S., Hobson, S., Rosenbrock, H., Lamla, T., Vercammen, J., Beste, G., Merchiers, P., Dorner‐Ciossek, C., & Lenter, M. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.1079

Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior

Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038